Systemic interleukin 10 administration inhibits brain tumor necrosis factor production in mice

European Journal of Pharmacology

Volumn 336, Issue 2-3, 1997, Pages 197-202

  Di Santo, Elena ^a   Adami, Marina ^b   Bertorelli, Rosalia ^b   Ghezzi, Pietro ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Schering Plough Research Institute   (Italy)

Author keywords

Brain; Interleukin 10; Lipopolysaccharide; TNF (tumor necrosis factor)

Indexed keywords

LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLOOD; BRAIN; BRAIN HOMOGENATE; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD; BRAIN; CELL LINE; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030720919     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01225-9     Document Type: Article

References (23)

1. Aggarwal B.B., Khor W.J., Hass P.E., Moffat B., Spencer S.A., Henzel J., Bringman S., Nedwin G.E., Goeddel D.V., Harkins R.N. Human tumor necrosis factor. Production, purification and characterization. J. Biol. Chem. 260:1985;2345-2354.
2. Blatteis C.M. Neuromodulative actions of cytokines. Yale J. Biol. Med. 63:1990;133-146.
3. Chernoff A.E., Granowitz E.W., Shapiro L., Vannier E., Lonnemann G., Angel J.B., Kennedy J.S., Rabson A.R., Wolff S.M., Dinarello C.A. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154:1995;5492-5499.
4. De Waal-Malefyt R., Abrams J., Bennet B., Figdor C., De Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1991;1209-1220.
5. Di Santo E., Sironi M., Pozzi P., Gnocchi P., Isetta A.M., Delvaux A., Goldman M., Marchant A., Ghezzi P. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1β production in the brain without affecting the activation of the hypothalamus-pituitary adrenal axis. Neuroimmunomodulation. 2:1995;149-154.
6. Faggioni R., Benigni F., Ghezzi P. Proinflammatory cytokines as pathogenetic mediators in the central nervous system: Brain-periphery connections. Neuroimmunomodulation. 2:1995;2-15.
7. Faggioni R., Fantuzzi G., Villa P., Buurman W., van Tits L.J.H., Ghezzi P. Independent down-regulation of central and peripheral TNF production by LPS tolerance. Infect. Immun. 63:1995;1473-1477.
8. Fantuzzi G., Di Santo E., Sacco S., Benigni F., Ghezzi P. Role of the hypothalamus-pituitary-adrenal axis in the regulation of tumor necrosis factor production in mice: Effect of stress and inhibition of endogenous glucocorticoids. J. Immunol. 155:1995;3552-3555.
9. Gérard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., Fiers W., Goldman M., Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:1993;547-550.
10. Grau G., Fajardo L.F., Piguet P.-F., Allet B., Lambert P.-H., Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science. 237:1987;210-213.
11. Gutierrez E.G., Banks W.A., Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47:1993;169-176.
12. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mice. Br. J. Pharmacol. 12:1957;12-15.
13. Jacobs L., O'Malley J., Freeman A., Ekes R. Intrathecal interferon reduces exacerbations of multiple sclerosis. Science. 214:1981;1026-1028.
14. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
15. Lipton J.M., Macaluso A., Hiltz M.E., Catania A. Central administration of the peptide α-MSH inhibits inflammation in the skin. Peptides. 12:1991;795-798.
16. Mengozzi M., Fantuzzi G., Faggioni R., Marchant A., Goldman M., Orencole S., Clark B.D., Sironi M., Benigni F., Ghezzi P. Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates interleukin 10 production in mice. Immunology. 82:1994;207-210.
17. Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 205:1994;1907-1915.
18. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
19. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
20. Saukkonen K., Sande S., Cioffe C., Wolpe S., Sherry B., Cerami A., Tuomanen E. The role of cytokines in the generation of inflammation and tissue damage in experimental Gram-positive meningitis. J. Exp. Med. 171:1990;439-448.
21. Sironi M., Gadina M., Kankova M., Riganti F., Mantovani A., Zandalasini M., Ghezzi P. Differential sensitivity of in vivo TNF and IL-6 production to modulation by antiinflammatory drugs in mice. Int. J. Immunopharmacol. 14:1992;1045-1050.
22. Stitt J.T., Bernheim H.A. Differences in endogenous pyrogen fevers induced by iv and icv routes in rabbits. J. Appl. Physiol. 59:1985;342-347.
23. The IFNB Multiple Sclerosis Study Group, The University of British Columbia MS/MRI Analysis Group, 1995. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology 45, 1277-1285.